Global Animal-base Gelatin Haemostatic Sponge Market Strategic Research Report

Scope of the Report

The global Animal-base Gelatin Haemostatic Sponge market size is predicted to grow from US$ 1,125 million in 2025 to US$ 1,482 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

Animal-based gelatin haemostatic sponge is a sterile, absorbable topical haemostat manufactured from purified gelatin derived from animal collagen sources (most commonly porcine or bovine). The material is processed into a porous sponge matrix that can be cut or shaped and applied directly to a bleeding surface during surgery or dental procedures. When placed on a wound, the sponge rapidly absorbs blood and exudate, swells, and provides a mechanical scaffold that supports platelet adhesion and clot formation; it can also be used with topical thrombin to accelerate haemostasis in oozing or diffuse bleeding. Because the sponge is bioresorbable, it is designed to be left in situ when removal is impractical, then gradually degraded and absorbed by the body over time, depending on product design and local conditions. Selection and safe use depend on the surgical site, available space (since swelling can create pressure in confined areas), required size and thickness, and compliance with sterility and biocompatibility requirements. Prices for Animal-base Gelatin Haemostatic Sponges vary widely by brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail). The gross profit margin of major companies in the industry is between 10% – 30%. Small dental cubes typically fall around $0.5–$2.0 per piece. Standard OR sheets/blocks are commonly $20–$40 per piece, while larger formats or premium branded packs can reach $80–$120 per piece. The gross profit margin of major companies in the industry is between 10% – 30%.

Global key Animal-base Gelatin Haemostatic Sponge players cover Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Animal-base Gelatin Haemostatic Sponge market?

What factors are driving Animal-base Gelatin Haemostatic Sponge market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Animal-base Gelatin Haemostatic Sponge market opportunities vary by end market size?

How does Animal-base Gelatin Haemostatic Sponge break out by Type, by Application?

This report presents a comprehensive overview of the global Animal-base Gelatin Haemostatic Sponge market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Porcine Gelatin Haemostatic Sponge
• Cow Gelatin Haemostatic Sponge
• Others

Segment by Product Form

• Sponge Sheets
• Sponge Particles
• Others

Segment by Application

• Hospitals
• Clinics
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Animal-base Gelatin Haemostatic Sponge market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals, Clinics, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact